Enzon Pharmaceuticals, Inc. (BST:EZ1)
Germany · Delayed Price · Currency is EUR 0.0595
0.00 (0.00%)
At close: Feb 5, 2026
Enzon Pharmaceuticals Revenue
In the year 2024, Enzon Pharmaceuticals had annual revenue of $26.00K USD.
Revenue
$26.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$26.00K
Employees
1
Market Cap
4.41M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 26.00K | -675.00K | -96.29% |
| Dec 31, 2021 | 701.00K | 649.00K | 1,248.08% |
| Dec 31, 2020 | 52.00K | -155.00K | -74.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InCity Immobilien AG | 36.54M |
| Vereinigte Filzfabriken AG | 24.77M |
| Schwabenverlag AG | 8.77M |
| Allerthal-Werke AG | 6.26M |
| Value-Holdings Aktiengesellschaft | 5.19M |
| Bürgerliches Brauhaus Ravensburg - Lindau Aktiengesellschaft | 2.49M |
| Nucletron Electronic Aktiengesellschaft | 583.88K |
| Horus AG | 540.95K |